Targeting chemical signals between the gut and brain could lead to new treatment for obesity

December 18, 2018

New research published in The Journal of Physiology has shed light on how to disrupt chemical signals that affect how much someone eats, which could lead to a method for helping manage obesity.

Obesity is one of today's most prevalent public health concerns. In the UK it affects around 1 in every 4 adults and around 1 in every 5 children aged 10 to 11.

Bariatric surgery has proven to be effective in weight loss; however, the availability, invasiveness and frequent complications of this procedure prevent its wide application. There is a lack of understanding about the underlying molecular mechanisms around obesity and there is growing evidence that targeting the nerve cells involved in sending signals between the brain and gut could provide promising therapies.

The vagus nerve plays an important role in regulating how much food someone eats and their metabolism by communicating between the gut and brain. This new research found that nitric oxide is responsible for decreasing the sensitivity of nerves that send messages from the gut to the brain about how full someone is after a meal.

The researchers showed that a specific enzyme (inducible nitric oxide synthase) was increased in obesity, which causes higher levels of nitric oxide. The study involved comparing mice fed a high fat diet with those fed a low fat diet. The researchers looked at the responses of the vagus nerve to normal meal stimulation. They found that in the mice with the high fat diet the nerve cells were less responsive and were less able to generate electrical signals which tell the brain to stop eating. They found the obese mice had an increased presence of nitric oxide, which reduces the sensitivity of the nerves and disrupts the normal chemical signals that would make the mice feel full. By blocking the enzyme that produces nitric oxide with specific drugs the sensitivity of the nerves was increased and normal chemical signals between the brain and gut was resumed.

The significance of these results will help us to better understand how obesity impairs the normal controls on eating, which in turn perpetuates the cycle of overeating and weight gain.

The study is limited in that the findings were in animals and not in humans. Furthermore observations made in the lab may not always translate to human subjects. Given that food intake was short lived there may be other mechanisms that take over in obesity that may continue to impair controls on food intake.

The researchers would like to look at what cell types are responsible for releasing excess nitric oxide and see what causes the increase in the obesity to see if the process can be affected before it begins.

Michael Beyak, corresponding author on the study said 'Obesity is one of the most prevalent public health concerns. It is associated with the chemical signals sent between the brain and gut being disrupted. Blocking the mechanism causing this disruption increases the sensitivity of the nerves involved and might help in the management of obesity.'

The Physiological Society

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to